Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
Cognition Therapeutics initiates US clinical testing of CT1812, a novel small molecule for the potential treatment of Alzheimer's disease
PITTSBURGH, PA, USA I December 13, 2016 I Cognition Therapeutics, Inc.
Switzerland’s Lonza would pay over $5 billion for drug-capsule maker
Private-equity firm KKR & Co.
Bayer, Versant invest $225 million in biotech venture
German healthcare group Bayer said on Monday it has set up a joint venture with U.
Achaogen's lead antibiotic succeeds two key studies; shares soar
Achaogen Inc's lead antibiotic was successful in two key studies, spurring the company to proceed with regulatory submissions in the United States and Europe, and shares soared 76 percent to their...
EIP Pharma announces positive results with neflamapimod (VX-745) in two Phase 2a clinical trials in patients with Early Alzheimer's Disease
CAMBRIDGE, MA, USAI December 8, 2016 I EIP Pharma, LLC (www.
Pharma’s bad jobs week gets worse: AstraZeneca to cut 700 U.S. positions
AstraZeneca’s $1.
Lilly presents phase II data on abemaciclib in early-stage breast cancer
Eli Lilly has announced that the neoMONARCH study of abemaciclib, a cyclin-dependent kinase (CDK) 4 and CDK 6 inhibitor, met its primary endpoint of reducing expression of Ki67, a biomarker of...
Arena Pharmaceuticals Completes Enrollment in Ralinepag Phase 2 Clinical Trial for Pulmonary Arterial Hypertension (PAH)
SAN DIEGO, Dec.
Cancer cases increase by 33% from 2005 to 2015: study
Cancer is the second leading cause of death worldwide and estimates of its burden around the globe are vital for cancer control planning.
Designer crystals fast-track vaccine development, help doctors
CANBERRA, Dec.
Cancer drug ibrutinib found helpful in treating graft versus host disease after transplant
A late-breaking abstract being presented today during the 58th American Society of Hematology (ASH) Annual Meeting and Exposition in San Diego shows patients who experience graft-versus-host d...
Novo files once-weekly GLP-1 analogue semaglutide
Novo Nordisk has filed its once-weekly glucagon-like peptide-1 (GLP-1) analogue semaglutide with regulators on both sides of the Atlantic, seeking permission to market the drug for the treatme...
588
589
590
591
592
593
594
595
596
